Die HIV-Infektion

Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS, Wormser G, Brettman L, Lange M, Murray HW, Cunningham-Rundles S (1981) An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular dysfunction. N Engl J Med 305: 1431–1438 Report on the global AIDS epidemic, executive summary 2006. Published by UNAIDS. May 2006 Puchhammer-Stöckl E (2006) HIV 2005. Virusepidemiologische Information Nr. 04/06 Tomkins S, Fortune N (2005) Occupational transmission of HIV, summary of published reports. March 2005 edition. Health Protection Agency Centre for Infections & Collaborators Schneider MF, Gange SJ, Williams CM, Anastos K, Greenblatt RM, Kingsley L, Detels R, Munoz A (2005) Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004. AIDS 19: 2009–2018 Epidemiologisches Bulletin des RKI, Nr. 47; 19. Nov. 2004 Arasteh K, Gölz J, Marcus U, Rockstroh J, Salzberger B, Vielhaber B (2004) Deutsch-Österreichische Richtlinien zur antiretroviralen Therapie der HIV-Infektion (Stand Mai 2004) Gazzard B (on behalf of the BHIVA Writing Committee) (2005) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Medicine 6 [Suppl 2]: 1–61 Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (May 4, 2006). Developed by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents – A Working Group of the Office of AIDS Research Advisory Council (OARAC). National Institutes of Health (NIH) Smith DE, Walker BD, Cooper DA, Rosenberg ES, Kaldor JM (2004) Is antiretroviral treatment of primary HIVinfection clinically justified on the basis of current evidence? AIDS 18: 709–718 Lipman M, Breen R (2006) Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis 19: 20–25 Kuhlmann B, Liess H (2004) Leitlinien der DAGNÄ zur Unterstützung der Adhärenz im Rahmen einer antiretroviralen Therapie bei HIV-Infektion. 4. überarbeitete Vorschlagsversion, verabschiedet am 11. September 2004 Epidemiologisches Bulletin des RKI, Nr. 47; 25. Nov. 2005 Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Masse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L; HPTN 050 Protocol Team (2006) Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS 20: 543–551 Buchholz B, Beichert M, Marcus U, Grubert T, Gingelmaier A, Haberl A, Schmied B (2005) Deutsch-Österreichische Empfehlungen zur HIV-Therapie in der Schwangerschaft und bei HIV-exponierten Neugeborenen – Update 2005 Postexpositionelle Prophylaxe der HIV-Infektion. Deutsch-österreichische Empfehlungen, Aktualisierung September 2004